We are live on ! Find out more
CD

Chapin Davis Portfolio holdings

AUM $569M
1-Year Est. Return 145.59%
This Fund
S&P 500
This Quarter Est. Return
+13.49%
1 Year Est. Return
+145.59%
3 Year Est. Return
+323.14%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$449M
AUM Growth
+$21.9M
Cap. Flow
-$2.61M
Cap. Flow %
-0.58%
Top 10 Hldgs %
27.98%
Holding
273
New
29
Increased
94
Reduced
89
Closed
12

Top Buys

Rank Stock Value
1
KEYS icon
Keysight
KEYS
+$8.88M
2
LRCX icon
Lam Research
LRCX
+$8.82M
3
CIEN icon
Ciena
CIEN
+$7.02M
4
MRNA icon
Moderna
MRNA
+$5.86M
5
CF icon
CF Industries
CF
+$5.45M

Top Sells

Rank Stock Value
1
MU icon
Micron Technology
MU
+$11.6M
2
APH icon
Amphenol
APH
+$6.86M
3
PLTR icon
Palantir
PLTR
+$6.84M
4
AVGO icon
Broadcom
AVGO
+$6.83M
5
IDXX icon
Idexx Laboratories
IDXX
+$5.54M

Sector Composition

Rank Sector Weight
1 Technology 35.28%
2 Financials 8.07%
3 Industrials 7.95%
4 Healthcare 6.91%
5 Materials 5.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SHW icon
251
Sherwin-Williams
SHW
$81.7B
$200K 0.04%
625
-345
-36% -$119K
BTZ icon
252
BlackRock Credit Allocation Income Trust
BTZ
$953M
$131K 0.03%
13,000
– –
PK icon
253
Park Hotels & Resorts
PK
$3B
$124K 0.03%
+11,750
New +$130K
F icon
254
Ford
F
$56.7B
$121K 0.03%
10,486
-2,650
-20% -$34.9K
MYI icon
255
BlackRock MuniYield Quality Fund III
MYI
$725M
$110K 0.02%
+10,500
New +$116K
SRTS icon
256
Sensus Healthcare
SRTS
$49.7M
$103K 0.02%
26,000
+16,000
+160% +$71K
HIO
257
Western Asset High Income Opportunity Fund
HIO
$344M
$97.7K 0.02%
26,909
-2,296
-8% -$8.55K
MRCC
258
DELISTED
Monroe Capital Corp
MRCC
$62.1K 0.01%
13,500
+1,500
+13% +$8.66K
YCBD icon
259
cbdMD
YCBD
$5.98M
$60.3K 0.01%
81,250
-1
-0% -$1
MGF
260
Aberdeen Government Markets Income Fund
MGF
$92.2M
$38.4K 0.01%
13,049
– –
LCTX icon
261
Lineage Cell Therapeutics
LCTX
$289M
$31.6K 0.01%
20,029
– –
BTI icon
262
British American Tobacco
BTI
$136B
– –
-7,913
Closed -$448K
CVS icon
263
CVS Health
CVS
$137B
– –
-2,642
Closed -$210K
ECL icon
264
Ecolab
ECL
$76.8B
– –
-819
Closed -$215K
EXPE icon
265
Expedia Group
EXPE
$32.3B
– –
-17,437
Closed -$4.94M
IDXX icon
266
Idexx Laboratories
IDXX
$44.8B
– –
-8,191
Closed -$5.54M
NRG icon
267
NRG Energy
NRG
$27.2B
– –
-3,424
Closed -$545K
OKE icon
268
Oneok
OKE
$58.9B
– –
-2,867
Closed -$211K
REGL icon
269
ProShares S&P MidCap 400 Dividend Aristocrats ETF
REGL
$1.78B
– –
-2,390
Closed -$201K
SCHX icon
270
Schwab US Large- Cap ETF
SCHX
$71.7B
– –
-7,783
Closed -$209K
SHBI icon
271
Shore Bancshares
SHBI
$776M
– –
-12,275
Closed -$217K
SHOP icon
272
Shopify
SHOP
$160B
– –
-1,500
Closed -$241K
TMO icon
273
Thermo Fisher Scientific
TMO
$198B
– –
-351
Closed -$204K
7 8 9 10
11

Similar funds

NWA
New World Advisors Hingham, Massachusetts $569M AUM 29.42% 1-Year Est. Return
ACM
ASK Capital Management San Francisco, California $568M AUM 82.82% 1-Year Est. Return
BRIM
Broad Run Investment Management Arlington, Virginia $568M AUM 50.18% 1-Year Est. Return
RIP
RAM Investment Partners Bellevue, Washington $569M AUM 16.27% 1-Year Est. Return
PSH
Pershing Square Holdings New York $569M AUM 14.61% 1-Year Est. Return
NHFG
New Harbor Financial Group Worcester, Massachusetts $567M AUM 41.38% 1-Year Est. Return
PPW
Presilium Private Wealth Radnor, Pennsylvania $567M AUM 12.93% 1-Year Est. Return
PAM
Peak Asset Management Louisville, Colorado $567M AUM 16.44% 1-Year Est. Return

Chapin Davis's Q1 2026 Portfolio in Review

As of Q1 2026, Chapin Davis held 273 positions worth $449M, up 5.1% from $427M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Chapin Davis's Q1 2026 filing shows 29 new, 94 increased, 89 reduced and 12 closed positions. Its largest new stake was Keysight: 35,434 shares worth $10M. The largest sale was Micron Technology, an estimated $11.6M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 34% a quarter earlier, followed by Financials and Industrials.

  • Chapin Davis's largest Q1 2026 buy was Keysight: 35,434 shares worth $10M.
  • Chapin Davis added most to Teradyne in Q1 2026, an estimated $2.84M increase.
  • Chapin Davis's biggest Q1 2026 reduction was Micron Technology, cutting an estimated $11.6M.
  • Chapin Davis fully exited Idexx Laboratories in Q1 2026, selling an estimated $5.54M.
  • Chapin Davis's ten largest holdings make up 28% of its $449M portfolio in Q1 2026.
  • Chapin Davis opened 29 new positions and closed 12 in Q1 2026.
  • Chapin Davis's portfolio value rose 5.1% quarter-over-quarter to $449M.

Based on Chapin Davis's 13F filing for Q1 2026, filed 21 Apr 2026.